查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1597886

遠距藥事照護市場：按服務、按應用分類 - 2025-2030 年全球預測

Telepharmacy Market by Services (Pharmacy Consultation, Remote Order Entry), End-Use (Hospitals, Primary Care Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，遠距藥事照護市場價值為10.4億美元，預計到2024年將達到11.5億美元，複合年成長率為10.03%，預計到2030年將達到20.4億美元。

遠距藥事照護是遠端醫療的一個子集，它透過與偏遠地區的患者進行通訊來實現藥物護理，從而增強藥物管理、患者諮詢和配藥。這一需求是由於醫療保健需求的增加、獲取藥房的地理障礙以及對具有成本效益的醫療保健服務的推動而產生的。應用範圍從藥物治療管理到慢性病管理再到農村醫療保健支援。遠距藥事照護的最終用途包括醫院、診所和社區健康中心，是彌合藥局服務差距的橋樑。關鍵的成長要素包括技術進步、遠端醫療的廣泛採用以及慢性病流行和人口老化推動的對遠距醫療解決方案的需求增加。將人工智慧整合到個人化護理、擴大本地醫療網路以及利用巨量資料分析來做出更好的決策等方面存在機會。然而，這個市場面臨區域監管差異、資料隱私問題以及虛擬確保製藥服務品質的挑戰等限制。創新可能集中在開發人工智慧主導的決策支援系統、用於即時監控的行動醫療應用程式以及用於安全資料處理的區塊鏈。與高科技公司合作建立遠端醫療平台可以實現無縫的遠距藥事照護體驗。此外，市場是動態的，科技公司、醫療保健系統和創新解決方案新興企業之間存在著激烈的競爭。戰略夥伴關係和對先進遠距遠端醫療技術的投資對於利用當前的成長勢頭至關重要。透過倡導統一標準來解決監管障礙可以緩解一些挑戰並增強市場進入。總而言之，遠距藥事照護透過改善醫療保健服務提供了顯著的成長途徑，但其未來取決於技術整合、不斷發展的法規和解決隱私問題，以及促進傳統醫藥保健生態系統的無縫擴展。

主要市場統計
基準年[2023] 10.4億美元
預測年份 [2024] 11.5億美元
預測年份 [2030] 20.4億美元
複合年成長率（%） 10.03%

市場動態：揭示快速發展的遠距藥事照護市場的關鍵市場洞察

供需的動態交互作用正在改變遠距藥事照護市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 遠端醫療和遠距保健的影響力日益增強
    • 網路用戶增加導致網路普及率成長
    • 降低成本和提高業務效率的好處
  • 市場限制因素
    • 遠距藥事照護相關法律法規的差異
  • 市場機會
    • 增加偏遠地區取得基本藥物的方法
    • 策略聯盟，提供高效率的遠距藥事照護服務
  • 市場挑戰
    • 認知度低且基礎設施支援有限

波特五力：駕馭遠距遠距藥事照護市場的策略工具

波特的五力框架是了解遠距藥事照護市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解遠距藥事照護市場的外部影響

外部宏觀環境因素在塑造遠距藥事照護市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解遠距藥事照護市場的競爭狀況

對遠距藥事照護市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣遠距遠距藥事照護市場供應商的績效評估

FPNV 定位矩陣是評估遠距藥事照護市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了遠距藥事照護市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，遠距藥事照護市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 遠端醫療和遠端保健的影響力日益增強
      • 網路普及率成長及網路使用者數量增加
      • 降低成本和提高營運效率的好處
    • 抑制因素
      • 遠距藥事照護相關法律法規的差異
    • 機會
      • 加大力度為偏遠地區提供基本藥物
      • 策略聯盟，提供高效率的遠距藥事照護服務
    • 任務
      • 認知度低且基礎設施支援有限
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章遠距藥事照護市場：依服務分類

  • 藥局諮詢
  • 遠程訂單輸入

第7章遠距藥事照護市場：依最終用途分類

  • 醫院
  • 基層醫療中心

第8章美洲遠距藥事照護市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區遠距遠距藥事照護市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的遠距藥事照護市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AMN Healthcare
  • Aspen RxHealth
  • Cardinal Health
  • CPS Solutions, LLC
  • Icebreaker Health, Inc.
  • Medication Review, Inc.
  • Medly Pharmacy
  • MedTel Services
  • Mitsui & Co., Ltd.
  • North West Telepharmacy Solutions
  • NURX Inc.
  • One Touch Telehealth
  • Pipeline Health, LLC
  • PipelineRx
  • Zava
Product Code: MRR-0360AB17E1CA

The Telepharmacy Market was valued at USD 1.04 billion in 2023, expected to reach USD 1.15 billion in 2024, and is projected to grow at a CAGR of 10.03%, to USD 2.04 billion by 2030.

Telepharmacy, a subset of telehealth, enables pharmaceutical care delivery via telecommunications to patients in remote areas, enhancing medication management, patient counseling, and dispensing. Its necessity stems from increasing healthcare demand, geographic barriers to pharmacy access, and the drive for cost-effective health services. Applications are wide-ranging, from medication therapy management to chronic disease management and rural healthcare outreach. End-use spans hospitals, clinics, and community health centers, with telepharmacy serving as a bridge to fill the pharmaceutical care gap. Key growth factors include technological advancements, the proliferation of telemedicine, and rising demand for remote healthcare solutions, spurred by chronic disease prevalence and an aging population. Opportunities lie in the integration of AI to personalize care, expanding rural healthcare networks, and leveraging big data analytics for better decision-making. However, the market faces limitations such as regulatory discrepancies across regions, data privacy concerns, and the challenge of ensuring pharmaceutical service quality virtually. Innovations may focus on developing AI-driven decision support systems, mobile health apps for real-time monitoring, and blockchain for secure data handling. Collaboration with tech companies for integrated telehealth platforms can allow for seamless telepharmacy experiences. Moreover, the market is dynamic, with robust competition among tech firms, healthcare systems, and startups innovating solutions. Strategic partnerships and investments in advanced telehealth technologies are essential to capitalize on current growth momentum. Addressing regulatory hurdles by advocating for uniform standards can mitigate some challenges, enhancing market access. In conclusion, while telepharmacy offers significant growth avenues through enhancing healthcare access, its future will hinge on technological integration, regulatory evolution, and addressing privacy concerns, facilitating its seamless expansion into traditional pharmaceutical care ecosystems.

KEY MARKET STATISTICS
Base Year [2023] USD 1.04 billion
Estimated Year [2024] USD 1.15 billion
Forecast Year [2030] USD 2.04 billion
CAGR (%) 10.03%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Telepharmacy Market

The Telepharmacy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising influence of telemedicine and telehealth
    • Growth in internet penetration coupled with rising internet users
    • Benefits of cost savings and operational efficiencies
  • Market Restraints
    • Differences in laws and regulations related to telepharmacy
  • Market Opportunities
    • Increasing approach to avail the essential drugs in remote areas
    • Strategic alliances to provide efficient telepharmacy services
  • Market Challenges
    • Less awareness and limited infrastructure support

Porter's Five Forces: A Strategic Tool for Navigating the Telepharmacy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Telepharmacy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Telepharmacy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Telepharmacy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Telepharmacy Market

A detailed market share analysis in the Telepharmacy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Telepharmacy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Telepharmacy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Telepharmacy Market

A strategic analysis of the Telepharmacy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Telepharmacy Market, highlighting leading vendors and their innovative profiles. These include AMN Healthcare, Aspen RxHealth, Cardinal Health, CPS Solutions, LLC, Icebreaker Health, Inc., Medication Review, Inc., Medly Pharmacy, MedTel Services, Mitsui & Co., Ltd., North West Telepharmacy Solutions, NURX Inc., One Touch Telehealth, Pipeline Health, LLC, PipelineRx, and Zava.

Market Segmentation & Coverage

This research report categorizes the Telepharmacy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Pharmacy Consultation and Remote Order Entry.
  • Based on End-Use, market is studied across Hospitals and Primary Care Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising influence of telemedicine and telehealth
      • 5.1.1.2. Growth in internet penetration coupled with rising internet users
      • 5.1.1.3. Benefits of cost savings and operational efficiencies
    • 5.1.2. Restraints
      • 5.1.2.1. Differences in laws and regulations related to telepharmacy
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing approach to avail the essential drugs in remote areas
      • 5.1.3.2. Strategic alliances to provide efficient telepharmacy services
    • 5.1.4. Challenges
      • 5.1.4.1. Less awareness and limited infrastructure support
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Telepharmacy Market, by Services

  • 6.1. Introduction
  • 6.2. Pharmacy Consultation
  • 6.3. Remote Order Entry

7. Telepharmacy Market, by End-Use

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Primary Care Centers

8. Americas Telepharmacy Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Telepharmacy Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Telepharmacy Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AMN Healthcare
  • 2. Aspen RxHealth
  • 3. Cardinal Health
  • 4. CPS Solutions, LLC
  • 5. Icebreaker Health, Inc.
  • 6. Medication Review, Inc.
  • 7. Medly Pharmacy
  • 8. MedTel Services
  • 9. Mitsui & Co., Ltd.
  • 10. North West Telepharmacy Solutions
  • 11. NURX Inc.
  • 12. One Touch Telehealth
  • 13. Pipeline Health, LLC
  • 14. PipelineRx
  • 15. Zava

LIST OF FIGURES

  • FIGURE 1. TELEPHARMACY MARKET RESEARCH PROCESS
  • FIGURE 2. TELEPHARMACY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TELEPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TELEPHARMACY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TELEPHARMACY MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TELEPHARMACY MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TELEPHARMACY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TELEPHARMACY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES TELEPHARMACY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES TELEPHARMACY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. TELEPHARMACY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. TELEPHARMACY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TELEPHARMACY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TELEPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TELEPHARMACY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TELEPHARMACY MARKET DYNAMICS
  • TABLE 7. GLOBAL TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TELEPHARMACY MARKET SIZE, BY PHARMACY CONSULTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TELEPHARMACY MARKET SIZE, BY REMOTE ORDER ENTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TELEPHARMACY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TELEPHARMACY MARKET SIZE, BY PRIMARY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES TELEPHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. TELEPHARMACY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. TELEPHARMACY MARKET, FPNV POSITIONING MATRIX, 2023